Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
0.572
0.00 (0.07%)
At close: Jan 14, 2025, 4:00 PM
0.603
+0.031 (5.40%)
Pre-market: Jan 15, 2025, 8:00 AM EST
Quoin Pharmaceuticals Employees
Quoin Pharmaceuticals had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,175,269
Market Cap
2.89M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4 | 0 | - |
| Dec 31, 2022 | 4 | 0 | - |
| Dec 31, 2021 | 4 | 2 | 100.00% |
| Dec 31, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
QNRX News
- 9 days ago - Quoin Pharmaceuticals Announces Additional Positive Interim Data from Ongoing Open-Label Netherton Syndrome Clinical Study - GlobeNewsWire
- 25 days ago - Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering - GlobeNewsWire
- 27 days ago - Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study - GlobeNewsWire
- 4 weeks ago - Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies - GlobeNewsWire
- 2 months ago - Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024 - GlobeNewsWire
- 4 months ago - Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO - GlobeNewsWire
- 5 months ago - Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome - GlobeNewsWire